Vida Ventures, LLC's Form 4 filing
Kyverna Therapeutics, Inc.KYTX · filed Feb 14, 2024
- Accession no.
- 0000950170-24-015479
- Filed
- Feb 14, 2024, 7:04 PM ET
- Trade date
- Feb 12, 2024
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 3 non-derivative transactions and 3 derivative transactions. Open-market purchases total $5.57M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Vida Ventures, LLCCIK 0001724489 | 10% Owner |
| Vida Ventures GP III, L.L.C.CIK 0001855502 | 10% Owner |
| Vida Ventures III-A, L.P.CIK 0001855503 | 10% Owner |
| Vida Ventures III, L.P.CIK 0001855504 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 12, 2024 | Common Stock | CConversionAcquired | +4,523,924 | –F1 | – | 4,523,924 | Indirect | Duplicate filing |
| Feb 12, 2024 | Common Stock | PPurchaseAcquired | +252,553 | $22.00 | +$5,556,166 | 252,553 | Indirect | |
| Feb 12, 2024 | Common Stock | PPurchaseAcquired | +583 | $22.00 | +$12,826 | 583 | Indirect |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 12, 2024 | Common Stock | CConversionDisposed | −967,188 | $0.00 | $0 | 0 | Indirect | Duplicate filing |
| Feb 12, 2024 | Common Stock | CConversionDisposed | −1,940,388 | $0.00 | $0 | 0 | Indirect | Duplicate filing |
| Feb 12, 2024 | Common Stock | CConversionDisposed | −1,616,348 | $0.00 | $0 | 0 | Indirect | Duplicate filing |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
Represents shares of the Issuer's Common Stock received upon conversion of shares of the reported series of preferred stock on a 1-for-4.5511 basis without payment of further consideration.
Referenced by the price of 1 transaction in Table I.